Compare EXPE & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPE | ALC |
|---|---|---|
| Founded | 1996 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Transportation Services | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.5B | 34.1B |
| IPO Year | 2005 | 2002 |
| Metric | EXPE | ALC |
|---|---|---|
| Price | $282.62 | $65.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 29 | 12 |
| Target Price | ★ $275.89 | $89.38 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.77% | 0.25% |
| EPS Growth | ★ 9.61 | N/A |
| EPS | ★ 7.05 | N/A |
| Revenue | ★ $14,733,000,000.00 | N/A |
| Revenue This Year | $10.35 | $7.99 |
| Revenue Next Year | $6.93 | $6.38 |
| P/E Ratio | $39.58 | ★ $38.31 |
| Revenue Growth | ★ 7.61 | N/A |
| 52 Week Low | $185.34 | $61.84 |
| 52 Week High | $342.00 | $87.64 |
| Indicator | EXPE | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 30.79 |
| Support Level | $277.25 | $63.91 |
| Resistance Level | $298.11 | $68.25 |
| Average True Range (ATR) | 11.15 | 1.24 |
| MACD | -2.53 | -0.61 |
| Stochastic Oscillator | 36.33 | 6.24 |
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of 2025 sales), air tickets (3%), rental cars, cruises, in-destination, and other (9%), and advertising revenue (8%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.